Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T14:19:21.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The date has been updated from February 12, 2025, to April 17, 2025.
    Difference
    0.7%
    Check dated 2025-04-23T12:30:14.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T10:18:31.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 12, 2025, while a date for March 25, 2025, has been removed.
    Difference
    1.0%
    Check dated 2025-04-09T04:47:09.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T19:02:13.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The date for results has been updated from November 6, 2024, to February 12, 2025, indicating a significant delay in the results posting schedule.
    Difference
    1%
    Check dated 2025-02-17T12:58:47.000Z thumbnail image

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.